Publication:
Cultural adaptation and validation of a peninsular Spanish version of the MSTCQ(C) Multiple sclerosis; (Multiple Sclerosis Treatment Concerns Questionnaire)

dc.contributor.authorMunteis Olivas, E.
dc.contributor.authorNavarro Mascarell, G.
dc.contributor.authorMeca Lallana, J.
dc.contributor.authorMaestre Martinez, A.
dc.contributor.authorPerez Sempere, A.
dc.contributor.authorGracia Gil, J.
dc.contributor.authorPato Pato, A.
dc.contributor.authoraffiliation[Munteis Olivas, E.] Hosp del Mar, Barcelona, Spain
dc.contributor.authoraffiliation[Navarro Mascarell, G.] Hosp Virgen de la Macarena, Seville, Spain
dc.contributor.authoraffiliation[Meca Lallana, J.] Hosp Clin Univ Virgen de la Arrixaca, Unidad Esclerosis Milltiple, Murcia, Spain
dc.contributor.authoraffiliation[Meca Lallana, J.] UCAM Univ Catal San Antonio Murcia, Catedra Neuroinmunol Clin & Esclerosis Multiple, Murcia, Spain
dc.contributor.authoraffiliation[Maestre Martinez, A.] Hosp Jaen, Jaen, Spain
dc.contributor.authoraffiliation[Perez Sempere, A.] Hosp Gen Alicante, Alicante, Spain
dc.contributor.authoraffiliation[Gracia Gil, J.] Hosp Albacete, Albacete, Spain
dc.contributor.authoraffiliation[Pato Pato, A.] Hosp Povisa, Vigo, Pontevedra, Spain
dc.date.accessioned2023-02-12T02:21:03Z
dc.date.available2023-02-12T02:21:03Z
dc.date.issued2017-01-01
dc.description.abstractIntroduction: Although subcutaneous treatments for multiple sclerosis (MS) have been shown to be effective, adverse reactions and pain may adversely affect treatment satisfaction and adherence. This study presents an adapted and validated Spanish version of the Multiple Sclerosis Treatment Concerns Questionnaire (c) (MSTCQ), which evaluates satisfaction with the injection device (ID) across 4 domains: injection system (A), side effects (B) (flu-like symptoms, reactions, and satisfaction), experience with treatment (C) and benefits (D). Methods: Two study phases: 1) Cultural adaptation process with input from experts (n = 6) and patients (n = 30). 2) Validation obtained by means of an observational, cross-sectional, multi centre study evaluating 143 adult MS patients using an ID. Tools employed: MSTCQ, Patient Reported Indices for Multiple Sclerosis (PRIMUS), and Treatment Satisfaction Questionnaire for Medication (TSQM (c)). Psychometric properties: Feasibility (percentage of valid cases and floor/ceiling effects); Reliability (Cronbach alpha) and test-retest correlation (n =41, intractass correlation coefficient, ICC); and construct validity (factor analysis of domains A and B) and convergent validity (Spearman rank-order correlation for MSTCQ (c) vs TSQM (c)). Results: Mean age (SD) was 41.94 (10.47) years, 63% of the group were women, and 88.11% presented relapsing-remitting MS. Mean (SD) EDSS score was 2.68 (1.82) points. MSTCQ (c) completion was high (0%-2.80% missing data). Internal consistency was high at alpha = 0.89 for the total score (A+ B) and alpha = 0.76, 0.89, and 0.92 for domains A, B, and C, respectively. The version demonstrated excellent test-retest reliability for the total (ICC = 0.98) and for domains A, B, and C: ICC =0.82, 0.97, and 0.89, respectively. Factor analysis corroborated the internal structure of the original questionnaire. The association between total and domain scores on both the MSTCQ (c) and the TSQM (c) was moderately strong (Rho = 0.42-0.74) and significant (P
dc.identifier.doi10.1016/j.nrl.2014.12.011
dc.identifier.essn1578-1968
dc.identifier.issn0213-4853
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.nrl.2014.12.011
dc.identifier.urihttp://hdl.handle.net/10668/18851
dc.identifier.wosID394559500005
dc.issue.number1
dc.journal.titleNeurologia
dc.journal.titleabbreviationNeurologia
dc.language.isoes
dc.organizationHospital Universitario de Jaén
dc.organizationHospital Universitario Virgen Macarena
dc.page.number29-39
dc.publisherElsevier doyma sl
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectMultiple sclerosis
dc.subjectPatient satisfaction
dc.subjectInjection system
dc.subjectQuestionnaire
dc.subjectReactions
dc.subjectValidation
dc.subjectInterferon beta-1b
dc.subjectSatisfaction
dc.subjectMulticenter
dc.subjectPerceptions
dc.subjectAdherence
dc.subjectDisease
dc.subjectDevice
dc.titleCultural adaptation and validation of a peninsular Spanish version of the MSTCQ(C) Multiple sclerosis; (Multiple Sclerosis Treatment Concerns Questionnaire)
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeArticle
dspace.entity.typePublication

Files